Elevated BMI and increased abdominal subcutaneous fat thickness are significantly associated with higher daily insulin requirements in GDM. Abdominal subcutaneous fat thickness, as a non-invasive, readily accessible, and objective ultrasound marker, is a valuable adjunct to BMI for predicting insulin needs in GDM management.
Arkan et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: